Ginseng / IL6 Cancer Research Results

Gins, Ginseng: Click to Expand ⟱
Features:

Ginseng = adaptogenic herbal root from the genus Panax; main species: Asian ginseng (Panax ginseng) and American ginseng (Panax quinquefolius). Active constituents: ginsenosides (Rb1, Rg1, Rg3, Rh2), polysaccharides, and other saponins.
Primary mechanisms (conceptual rank):
1) Multi-pathway signaling modulation (PI3K/Akt, MAPK, NF-κB; isoform-dependent).
2) Redox regulation (bidirectional ROS modulation; NRF2 interaction).
3) Anti-inflammatory and immunomodulatory effects.
4) Anti-proliferative and pro-apoptotic effects in cancer (notably Rg3, Rh2; dose-dependent).
5) Neurotrophic and cholinergic modulation (BDNF, ACh support).
PK / bioavailability: ginsenosides have variable oral absorption; gut microbiota convert to active metabolites (e.g., Compound K); plasma levels generally lower than many in-vitro doses.
In-vitro vs systemic exposure: many cancer studies use ≥10–100 µM; achievable plasma concentrations after oral dosing are typically lower and metabolite-driven.
Clinical evidence status: supportive oncology (fatigue reduction) supported by RCTs; direct anti-cancer efficacy largely preclinical; cognitive and fatigue benefits better substantiated.

Ginseng (Panax ginseng) – This herb has been studied for its ability to enhance the immune system.
-Antioxidant Properties: Ginseng contains ginsenosides, which have antioxidant properties.
-Immune System Support
-Inhibition of Tumor Growth
-Chemopreventive Effects
-Synergistic Effects with Cancer Treatments: ginseng may enhance the effectiveness of certain cancer treatments, such as chemotherapy, and may help reduce side effect
Dose: Standardized Extract:
Dosage: extract containing 4-7% ginsenosides 200-400mg/d
Dried Root:1-2g/d
Tea: 1-2g dried root, 1-3x/d

Ginseng (Panax spp.) — Cancer-Relevant Pathways

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 PI3K/Akt / MAPK signaling ↓ proliferation (isoform-dependent) ↔ / adaptive support R→G Growth signaling attenuation Ginsenosides Rg3/Rh2 most studied; context- and tumor-type dependent.
2 Apoptosis (caspase / mitochondrial) ↑ (dose-dependent) ↔ / protective R→G Pro-apoptotic signaling Mitochondrial depolarization reported; supra-physiologic concentrations common in vitro.
3 ROS modulation ↑ (high concentration) / ↓ (adaptive) ↓ P→R Redox modulation Bidirectional: pro-oxidant cytotoxicity in tumors at high dose; antioxidant in normal cells.
4 NF-κB / inflammation ↓ ↓ R→G Anti-inflammatory Reduces pro-tumor inflammatory microenvironment signals.
5 Angiogenesis (VEGF) ↓ (preclinical) ↔ G Anti-angiogenic Reported particularly with Rg3; human oncologic outcome data limited.
6 NRF2 axis ↔ / ↑ (adaptive) ↑ G Antioxidant enzyme induction Protective in normal tissues; tumor resistance context-dependent.
7 Clinical Translation Constraint — — — Adjunct role RCTs support fatigue reduction in cancer patients; direct anti-tumor efficacy not established.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr


Ginseng (Panax spp.) — Alzheimer’s Disease–Relevant Axes

Rank Pathway / Axis Cells (neurons/glia) TSF Primary Effect Notes / Interpretation
1 BDNF / neuroplasticity ↑ G Neurotrophic support Rg1 and metabolites reported to enhance BDNF signaling; supports cognition in mild impairment models.
2 Cholinergic modulation ↑ (mild) R→G ACh support May increase ACh release or inhibit AChE modestly; relevance additive to standard therapy unclear.
3 Neuroinflammation (NF-κB) ↓ R→G Microglial modulation Reduces pro-inflammatory cytokines in animal models.
4 ROS / oxidative stress ↓ P→R Antioxidant support Induces antioxidant enzymes; may protect against Aβ-induced oxidative injury.
5 Aβ processing ↓ (preclinical) G Reduced amyloid burden Animal studies suggest modulation of APP processing; human AD RCT data limited.
6 Clinical Translation Constraint — — Modest cognitive benefit Small human trials suggest mild cognitive improvement; not disease-modifying.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr
IL6, Interleukin-6: Click to Expand ⟱
Source: HalifaxProj(inhibit)
Type:
Interleukin-6 (IL-6) is a cytokine that plays a significant role in inflammation and the immune response. It is produced by various cell types, including T cells, B cells, macrophages, and fibroblasts.
IL-6 can promote tumor cell proliferation and survival. Many cancer cells produce IL-6, which can create an autocrine loop that supports their growth.
IL-6 is a high-value inflammatory biomarker in cancer, reporting cytokine burden, catabolic stress, and STAT3-linked survival signaling. While not tumor-specific, elevated and rising IL-6 strongly predicts poor prognosis and limited treatment tolerance, making it an important system-state indicator alongside CRP and ferritin.


Scientific Papers found: Click to Expand⟱
4003- Gins,    Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences
- Review, adrenal, NA
*neuroP↑, *Inflam↓, *ROS↓, *BACE↓, *PPARγ↑, *Aβ↓, *p‑tau↓, *NF-kB↓, *IL1β↓, *IL6↓, *TNF-α↓, *ROS↓, *CREB↓, *BDNF↑, *memory↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

ROS↓, 2,  

Core Metabolism/Glycolysis ⓘ

CREB↓, 1,   PPARγ↑, 1,  

Immune & Inflammatory Signaling ⓘ

IL1β↓, 1,   IL6↓, 1,   Inflam↓, 1,   NF-kB↓, 1,   TNF-α↓, 1,  

Synaptic & Neurotransmission ⓘ

BDNF↑, 1,   p‑tau↓, 1,  

Protein Aggregation ⓘ

Aβ↓, 1,   BACE↓, 1,  

Clinical Biomarkers ⓘ

IL6↓, 1,  

Functional Outcomes ⓘ

memory↑, 1,   neuroP↑, 1,  
Total Targets: 15

Scientific Paper Hit Count for: IL6, Interleukin-6
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:219  Target#:158  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page